0 reactions
indianmarketgrid In a small early-stage trial, 77% of 31 evaluable patients at one dose had a PSA decline of at least 50%.
READ FULL ANALYSIS MEMBER ANALYSIS
THE IMG COMMUNITY
Market insights. Fresh perspectives. Your conversation.
indianmarketgrid In a small early-stage trial, 77% of 31 evaluable patients at one dose had a PSA decline of at least 50%.